Articles From: Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens to Village Super Market, Inc. Reports Results for the Quarter and Year Ended July 27, 2013


Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens Canada NewsWire Lens Design Features Advanced Optics and MoistureSeal™ Technology to Provide Unsurpassed Comfort LAVAL, Quebec , Oct.
Sign-up for Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens investment picks
VISALIA, Calif.
Sign-up for Valley Commerce Bancorp Declares Cash Dividend investment picks
Vanguard Investments Canada Inc. today announced the final December 2013 cash distributions for the Vanguard ETFs listed on Toronto Stock Exchange (TSX). Please note that any capital gains distributions for the Vanguard ETFs will be reported separately .
Sign-up for Vanguard Announces Final Cash Distributions for the Vanguard ETFs (VCE, VCN, VDY, VRE, VUS, VUN, VSP, VFV, VGH, VGG, VEF, VDU, VEE, VAB, VSB, and VSC) investment picks
Vanguard Natural Resources, LLC (NASDAQ: VNR) (“Vanguard”) has declared a cash distribution for its 7.875% Series A Cumulative Redeemable Perpetual Preferred Units (“VNRAP”) of $0.1641 per unit payable on September 13, 2013 to unitholders of record on September 6, 2013.
Sign-up for Vanguard Natural Resources Announces Series A Preferred Units Monthly Distribution investment picks
New interface now connects Varian software with Siemens' ARTISTE medical linear accelerators ATLANTA , Sept.
Sign-up for Varian and Siemens to Showcase Collaborative Offerings at 2013 ASTRO Meeting in Atlanta investment picks
Vector Group Ltd.
Sign-up for Vector Group Acquires Additional 20.59% Interest in Douglas Elliman Realty investment picks
- Affiliates of GSO Capital Partners LP acquire debt from HSBC - Sale Expected to Close by End of 2013 - Operations for Acquired Businesses to Continue as Normal Throughout the Sale Process; Receive Additional Financing - Velti's Other European, Asian, South American and Middle Eastern Businesses to Continue Operations as Normal SAN FRANCISCO , Nov.
Sign-up for Velti Announces Agreement to Sell Mobile Marketing Businesses in U.S., U.K., and India to Affiliates of GSO Capital Partners LP investment picks
SAN FRANCISCO , Jan.
Sign-up for Velti Closes Sale of Mobile Marketing Business to GSO Capital Partners investment picks
SAN DIEGO and DUBLIN , Aug.
Sign-up for Velti Plc Sued by Investor investment picks
CASTLE ROCK, Colo.
Sign-up for Venaxis' APPY1™ Test Passes Final Futility Analysis in Pivotal Clinical Study investment picks
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it will issue its fourth quarter and year-end 2013 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, February 14, 2014.
Sign-up for Ventas Announces Fourth Quarter and Year-End 2013 Earnings Release Date and Conference Call investment picks
Veolia Energy North America, a leading provider of sustainable energy services, and I Squared Capital, a global infrastructure investment firm, entered into an agreement with NRG North America LLC, an affiliate of NRG Energy, Inc. to purchase its 256-megawatt Kendall Station, located in Cambridge, Mass.
Sign-up for Veolia and I Squared Capital Set to Acquire Kendall Cogeneration Station, Expanding “Green Energy” Footprint in Greater Boston Area investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for Veracyte, Inc. Announces Closing of Initial Public Offering investment picks
Verint ® Systems Inc. (NASDAQ: VRNT) today announced that it has been positioned in the “Leaders” quadrant of the newly published “Magic Quadrant for Contact Center Workforce Optimization” report from research and advisory firm Gartner, Inc. Verint’s standing in the firm’s November 20, 2013 report is based on the company’s ability to execute and completeness of vision.
Sign-up for Verint Placed in “Leaders” Quadrant of Gartner 2013 Magic Quadrant for Contact Center Workforce Optimization investment picks
Veris Gold Corp.
Sign-up for Veris Gold Corp. reports results for third quarter of 2013 investment picks
Verizon Foundation Will Match Employees' Donations to Red Cross; Verizon Wireless Customers Can Text Donations WASHINGTON, Ill.
Sign-up for Verizon Commits $50,000 Grant; Enlists Employees, Customers to Assist Illinois Tornado Victims investment picks
Transaction Provides Verizon with 100 Percent Ownership of Verizon Wireless Enhances Ability to Provide Customers with Seamless and Integrated Services Transaction Expected to be Immediately Accretive to Verizon's EPS Verizon Board Authorizes 2.9 Percent Increase in Quarterly Dividend NEW YORK , Sept.
Sign-up for Verizon Reaches Agreement To Acquire Vodafone's 45 Percent Interest In Verizon Wireless For $130 Billion investment picks
By Jeffry Bartash, MarketWatch WASHINGTON (MarketWatch) -- Verizon Communications and Vodafone Group PLC reportedly have worked out terms of a deal to allow the U.S. carrier to buy out its U.K.-based partner for $130 billion, giving the American company sole control over Verizon Wireless.
Sign-up for Verizon, Vodafone close in on wireless sale investment picks
Aspen Technology, Inc. (NASDAQ: AZPN) , a leading provider of software and services to the process industries, announced the availability of the V8.3 release of aspenONE software.
Sign-up for Version 8.3 of aspenONE® Software Transforms Acid Gas Cleaning and Delivers Industry-First in Pressure Safety Valve Sizing investment picks
Verso Paper Corp.
Sign-up for Verso Paper Corp. Reports Third Quarter 2013 Results investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq:VRTX) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECO TM (ivacaftor) monotherapy for people with cystic fibrosis (CF) ages 6 and older who have at least one non-G551D gating mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for KALYDECO™ (ivacaftor) Monotherapy for People with Non-G551D Gating Mutations investment picks
Expects to Declare Additional Special Cash Dividend of $1.50 per Share Payable in January 2014 PHOENIX , Oct.
Sign-up for Viad Corp Declares Special Cash Dividend Of $2.50 Per Share Payable On November 14, 2013 investment picks
Company Focusing Resources on Infectious Disease Vaccine Programs SAN DIEGO, Aug.
Sign-up for Vical Phase 3 Trial of Allovectin(R) Fails to Meet Efficacy Endpoints investment picks
SAN DIEGO, Oct.
Sign-up for Vical Publication Highlights Milestone in Vaccine Development investment picks
-- Executive a member of several financial organizations -- William C.
Sign-up for Vice chairman of board at BBVA Compass appointed to Texas Bankers Association board investment picks
With IMS Health FAN (Flu Activation Network) data showing that the flu is spreading fast, Vicks® is encouraging people to be prepared and take precautions.
Sign-up for Vicks® Encourages Consumers to Be Prepared as Flu Accelerates investment picks
SPRINGFIELD, N.J., Oct.
Sign-up for Village Super Market, Inc. Reports Results for the Quarter and Year Ended July 27, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Valeant Pharmaceuticals' Bausch + Lomb Receives U.S. FDA Clearance For Novel Monthly Disposable Contact Lens to Village Super Market, Inc. Reports Results for the Quarter and Year Ended July 27, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity